08 Aug Oncology Care Consolidation and the Changing Clinical Trial Environment
Can robust M&A activity have a direct benefit on cancer treatment? John Patterson speaks with Wes Chapman on how bringing together thought-leading oncology care professionals can accelerate clinical trials for new cancer drugs and treatment protocols....